• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

and Blood Institute NHLBI

Study: ECMO ‘significantly’ improves heart attack patients’ survival

November 13, 2020 By Sean Whooley

The National Institutes of Health (NIH) is touting a study that found the use of life support improved survival in certain cardiac arrest patients. Published in The Lancet, the study, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST) trial, used the life support machine called extracorporeal membrane oxygenation ECMO to replicate the […]

Filed Under: Cardiovascular, Clinical Trials, Featured Tagged With: Abiomed, and Blood Institute NHLBI, coronavirus, COVID-19, LivaNova, Medtronic, National Institutes of Health (NIH)

Feds give CytoSorbents’ blood filter a shot at $3 million

August 22, 2018 By Nancy Crotti

CytoSorbents (NASDAQ: CTSO)  said it has won another round of funding from the U.S. government to commercialize its HemoDefend red blood cell (RBC) transfusion filter. The critical-care immunotherapy company, based in Monmouth Junction, N.J., specializes in blood purification. The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health, granted the three-year, Phase IIB […]

Filed Under: Blood Management Tagged With: and Blood Institute NHLBI, CytoSorbents Corp., National Institutes of Health (NIH)

This new technique could make TAVR more available

April 3, 2018 By Chris Newmarker

A novel technique could prevent coronary artery obstruction — a rare but often fatal complication related to transcatheter aortic valve replacement (TAVR), according to the National Institutes of Health researchers who created it. The researchers at NIH’s National, Heart, Lung, and Blood Institute are calling the procedure Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA). […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, News Well, Replacement Heart Valves, Research & Development Tagged With: and Blood Institute NHLBI, Edwards Lifesciences, Lung, National Heart, National Institutes of Health (NIH), tavr

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS